[BDRX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- 38.99%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 674 1,938 989 1,323 1,375 157 147 28.87%
PBT -10,923 -12,400 -12,970 -8,388 -11,232 -9,840 -4,883 14.35%
Tax 1,785 2,032 1,265 2,227 1,133 1,018 799 14.32%
NP -9,138 -10,368 -11,705 -6,161 -10,099 -8,822 -4,084 14.35%
Tax Rate - - - - - - - -
Total Cost 9,812 12,306 12,694 7,484 11,474 8,979 4,231 15.04%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -1,355.79 -534.98 -1,183.52 -465.68 -734.47 -5,619.11 -2,778.23 -11.26%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -3,988.65 0.00 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -3,988.65 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.